t(14;17)(q32;q21) IGH/IGF2BP1
2014-10-01 Sarah South  , Guangyu Gu   Affiliation1.Genetics Associates, Inc. Nashville, TN [email protected] (GG); Department of Pathology, University of Utah; ARUP Institute for Clinical, Experimental Pathology, ARUP Laboratories, Salt Lake City, UT [email protected] (SS)
Abstract
IGH rearrangements are a common chromosomal abnormality seen in lymphoproliferative disorders, including ALL. Numerous translocation partners of IGH gene have been identified. Here we report a B-ALL case with a t(14;17)(q32;q21) IGH/IGF2BP1.
Clinics and Pathology
Disease
Phenotype stem cell origin
Epidemiology
Clinics
Genes Involved and Proteins
Result of the Chromosomal Anomaly
Description
Oncogenesis
Highly cited references
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 25195122 | 2014 | IGF2BP1: a novel IGH translocation partner in B acute lymphoblastic leukemia. | 0 |
Article Bibliography
| Pubmed ID | Last Year | Title | Authors |
|---|---|---|---|
| 23069990 | 2013 | Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? | Bell JL et al |
| 25195122 | 2014 | IGF2BP1: a novel IGH translocation partner in B acute lymphoblastic leukemia. | Gu G et al |
| 25068994 | 2014 | The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer. | Lederer M et al |
Summary
Fusion gene
Mesh

Citation
Sarah South ; Guangyu Gu
t(14;17)(q32;q21) IGH/IGF2BP1
Atlas Genet Cytogenet Oncol Haematol. 2014-10-01
Online version: http://atlasgeneticsoncology.org/haematological/1706/new-content/gene-explorer/
